Home/Lung Cancer
Condition Deep-Dive

Lung Cancer

The leading cause of cancer death globally. Smoking is the main cause; radon, air pollution and asbestos add to the risk1. Not smoking is the best prevention, and beta-carotene supplements raised lung cancer rates in smokers in two large randomized trials2.

Cancer Evidence-Based

Last updated:

โš ๏ธ Treatment safety: please read first. The nutrition and supplement approaches on this page are meant to work alongside cancer treatment, never to replace or delay it. Never stop, delay or change your treatment without your oncology team's guidance. Doing so can be dangerous. Several supplements interact with chemotherapy and other cancer treatments, so talk to your oncology team or pharmacist before starting anything on this page.
Definition

What Is Lung Cancer?

Lung cancer is the leading cause of cancer death worldwide1, and in both men and women in the US3. It arises from cells lining the airways (bronchogenic carcinoma) or alveoli, with most cases driven by carcinogen-induced DNA damage to lung epithelium.

Two main histologic categories: non-small cell lung cancer (NSCLC, around 85% of cases1, includes adenocarcinoma, squamous cell, large cell) and small cell lung cancer (SCLC, less common and typically more aggressive, strongly smoking-related). Modern treatment is increasingly stratified by molecular markers (EGFR, ALK, ROS1, KRAS, BRAF) and PD-L1 expression.

In the US, cigarette smoking is linked to about 80% of lung cancer deaths, but lung cancer also occurs in people who have never smoked, in whom radon, secondhand smoke, air pollution, workplace exposures such as asbestos, and inherited factors play a part4. Low-dose CT screening reduces lung cancer mortality in high-risk current/​former smokers, yet uptake remains low: 17% of eligible US adults had been screened in 2022 5.

๐Ÿšจ If you smoked 20+ pack-years and are age 50 to 80 (current or quit within 15 years), US guidance recommends annual low-dose CT screening5. In the NLST and NELSON trials, low-dose CT lowered lung cancer deaths by 20% against chest X-ray and by 24% in men against no screening6. This is one of the most underused preventive interventions in medicine.
Both lungs and the trachea, with a tumor in the lower part of one lung and lymph nodes where the airways branch

Major Lung Cancer Types

Adenocarcinoma

About 40% of lung cancers7. Most common in never-smokers and women. Often peripheral. Targetable mutations frequent (EGFR, ALK, ROS1, KRAS). Best response to targeted therapies and immunotherapy.

Squamous Cell

About 25% of lung cancers7. Strongly smoking-related. Often central, near major airways. May cause hemoptysis, post-obstructive pneumonia. Limited targetable mutations; immunotherapy increasingly important.

Small Cell

About 15% of lung cancers7. Aggressive, fast-growing, strongly smoking-related. Often disseminated at diagnosis. Usually responds at first to chemotherapy and radiation therapy; immunotherapy (atezolizumab) now standard for extensive stage.

By the Numbers

Lung Cancer by the Numbers

229,410
estimated new lung cancer diagnoses in the US in 2026 3
#1
cause of cancer death in both men and women in the US3
About 80%
of US lung cancer deaths are linked to cigarette smoking; people who smoke are 15 to 30 times more likely to get or die from lung cancer4
24%
of US lung cancers are found while still confined to the lung; about half have already spread to distant organs by diagnosis3
17%
of eligible US adults had low-dose CT screening in 2022, so most people who qualify are still not screened5
18 to 28%
more lung cancers in smokers given beta-carotene supplements (alone or with vitamin A) than placebo, in two large randomized trials2
Signs & Symptoms

Symptoms of Lung Cancer

Most early lung cancers are asymptomatic, found only by screening. By the time symptoms appear, disease is often advanced. Persistent symptoms in smokers warrant urgent evaluation.

SymptomWhat happens
Pulmonary Symptoms
Persistent CoughNew cough lasting >3 weeks, OR change in chronic smoker's cough. May be dry or productive. Don't dismiss in smokers.
Hemoptysis (Coughing Blood)Even small streaks of blood always need evaluation: more than a few streaks is an emergency; smaller streaks need an urgent appointment. May indicate central tumor erosion.
Shortness of BreathProgressive dyspnea, especially with exertion. May indicate tumor blocking airway, pleural effusion or lymphangitic spread.
Chest PainDull, aching pain. May worsen with deep breathing or cough. Pleural/​chest wall involvement. Shoulder pain may indicate Pancoast tumor.
Systemic & Advanced
Unexplained Weight Loss10+ pounds (4.5 kg) without trying. Combined with respiratory symptoms in smoker, urgent CT. Often paraneoplastic.
Profound FatigueDisproportionate to activity. Often paraneoplastic. Combined with constitutional symptoms (weight loss, night sweats) raises concern.
Bone Pain (Metastases)Persistent back, hip or rib pain. Lung cancer commonly metastasizes to bones. Sudden severe pain may indicate pathologic fracture.
Neurologic Symptoms (Brain Mets)Headache, seizures, vision changes, focal weakness. Lung cancer is the leading source of brain metastases. Some paraneoplastic syndromes (Lambert-Eaton, SIADH) are often linked to small cell lung cancer8, though both have other causes too.
Causes

Causes of Lung Cancer

Smoking is the main cause of lung cancer, but it also develops in people who have never smoked, and several other exposures add to the risk1.

CauseHow It Contributes to Lung CancerWhat Helps
SmokingCigarette smoking is the number one risk factor, and the more years and the more cigarettes, the higher the risk; even a few cigarettes a day raise it4Stopping, with stop-smoking support, at any point; risk goes down after quitting4
Secondhand smokeSmoke from other people's cigarettes, pipes or cigars also causes lung cancer4A smoke-free home and car
RadonRadon gas building up indoors is the second leading cause of lung cancer overall and the leading cause in people who have never smoked; the risk is higher in people who smoke9Home radon testing, and mitigation if levels are high, as the treatment section describes
Workplace exposures and air pollutionAsbestos, arsenic, diesel exhaust and some forms of silica and chromium raise the risk, more so in people who smoke, and so does living with more air pollution4Workplace protection; less indoor smoke and less outdoor exposure on poor air days, as the treatment section lists
Beta-carotene supplements in people who smokeBeta-carotene pills raise lung cancer risk, especially in people who smoke a pack a day or more, and more so with daily alcohol; beta-carotene from food does not4Not taking beta-carotene supplements if you smoke or have smoked; food sources are fine, as the diet section says2
Personal or family history, chest radiation therapy and HIVSurvivors can develop a second lung cancer, especially if they smoke; risk is higher with a close relative who had lung cancer, after radiation therapy to the chest or with HIV4Nothing changes these; they are reasons to report symptoms early and to ask about screening if you also meet the smoking criteria5
Diagnosis

How Lung Cancer Is Diagnosed

TestWhat it shows
Screening & Imaging
Low-Dose CT ScreeningUS: annual LDCT for adults aged 50 to 80 with a 20 pack-year smoking history who smoke now or quit within the past 15 years5. UK: people aged 55 to 74 who have ever smoked may be invited for a lung health check10. Low-dose CT screening lowered lung cancer deaths by 20% against chest X-ray in one large trial, and by 24% in men against no screening in another6.
Diagnostic CT ChestWhen symptoms present or screening finds nodule. Characterizes lesions, identifies mediastinal nodes, plans biopsy approach.
PET-CTFor staging, identifies metastases. Differentiates benign from malignant nodules (SUV uptake). Standard for stages I to III workup.
BiopsyCT-guided needle biopsy, bronchoscopy with ultrasound (EBUS) or keyhole chest surgery (VATS). Tissue for histology + molecular testing + PD-L1. Essential for treatment decisions.
Molecular & Staging
Molecular Testing (NSCLC)EGFR, ALK, ROS1, BRAF, MET, RET, KRAS, NTRK, HER2, EGFR Exon 20. Required for advanced adenocarcinoma. Determines targeted therapy options.
PD-L1 ExpressionImmunohistochemistry. Determines immunotherapy choice. High expression (โ‰ฅ50%) supports first-line pembrolizumab monotherapy11.
Liquid BiopsyBlood-based circulating tumor DNA (ctDNA) testing. Useful when tissue insufficient. Monitors response and resistance mutations during treatment.
Brain MRIStandard staging for stages II to IV NSCLC and all SCLC. Lung cancer is the leading cause of brain metastases.
Treatment Comparison

Conventional and Holistic Treatment for Lung Cancer

๐ŸŒฟ HOLISTIC
๐Ÿ’Š CONVENTIONAL
๐ŸŒฟ

Holistic / Functional Approach

For prevention (most important) + support during conventional treatment + survivorship

Active Treatment
Holistic = supportive only. Conventional oncology essential for any cure.
Prevention
In the US, smoking is linked to about 80% of lung cancer deaths4, and lung cancer is the leading cause of cancer death3; testing homes for radon and avoiding polluted air lower risk further
Survivorship
Exercise after surgery improved fitness, leg strength and breathlessness in randomized trials, though survival was not measured12
Avoid
High-dose antioxidants during chemo or radiation therapy (may reduce efficacy)13; beta-carotene supplements if you smoke or have smoked (raised lung cancer rates in two large randomized trials)2; the same caution applies to older eye-health formulas, see macular degeneration

Full Holistic Approach Includes

  • Smoking cessation, the most important step. Risk falls substantially in the years after quitting14. Even after diagnosis, quitting is linked with longer survival and fewer recurrences in observational studies14.
  • Radon testing & mitigation: radon is the second leading cause of lung cancer overall9. Free/cheap home testing. Mitigation systems install easily.
  • Reduce indoor air pollution: HEPA filters, ventilation, caution with gas stoves, no wood or incense burning indoors
  • Reduce outdoor air pollution exposure, monitor AQI, exercise when the air is cleaner, N95 masks when AQI poor
  • Mediterranean / cruciferous-rich diet: in people who smoke or used to smoke, vegetables and fruit may lower risk, though the evidence is limited15. Cooked tomatoes, leafy greens, cruciferous vegetables daily.
  • Correcting low vitamin D for its own sake; low levels are linked with worse outcomes in observational studies, but in a trial after surgery vitamin D did not improve survival20
  • Avoid beta-carotene supplements in smokers2: the CARET trial showed increased lung cancer risk. Food sources are safe.
  • Avoid high-dose antioxidant supplements during chemo or radiation therapy: they may reduce treatment efficacy. Food sources are safe.
  • During treatment: adequate protein (1 to 1.5 g/kg), maintain weight, address nausea
  • Exercise as tolerated, improved fitness and breathlessness after surgery in randomized trials12
  • Acupuncture, for chemo-induced nausea, neuropathy
  • Mind-body practices, meditation, yoga, support groups improve quality of life
  • Pulmonary rehabilitation, for those with reduced lung function
  • Address depression, common; treat aggressively
โš ๏ธ Critical Safety Note: Lung cancer is much more treatable when caught early. If you have a smoking history, ask your doctor about LDCT screening. Holistic approaches help with prevention and supportive care; they cannot replace surgery, targeted therapy, immunotherapy or chemotherapy for active disease.
Supplement Protocol

Evidence-Based Supplements for Lung Cancer

Important: coordinate with oncology, because many supplements can interfere with chemo, targeted therapy and immunotherapy. None of these treats lung cancer, and probiotic supplements are not advised during immunotherapy19.

SupplementWhat it is forTypical rangeTimingNotes & cautions
Vitamin D3Low levels are linked with worse outcomes in observational studies, but in a randomized trial of 155 people after lung cancer surgery, a year of vitamin D did not improve relapse-free or overall survival; a benefit appeared only in a subgroup with early-stage adenocarcinoma and low vitamin D20.Not recommended for lung cancer (a year of vitamin D after surgery did not improve survival)Not applicableIf your clinician finds a deficiency, it is treated for its own sake.
Omega-⁠3 (EPA/DHA)Studied for weight and muscle loss in cancer: a 2026 review of trials found small gains in quality of life but inconsistent effects on weight and lean mass21. Anti-inflammatory.Not recommended for weight and muscle loss in cancer (a 2026 review found inconsistent effects on weight and lean mass)Not applicableDiscuss with oncologist; possible interaction with some treatments. In heart trials, fish oil supplements raised the risk of atrial fibrillation, an irregular heartbeat, more so above 1 g a day22, so check any fish oil supplement with your clinician first.
CurcuminNot shown to help lung cancer: it is anti-inflammatory and anti-proliferative in the lab, but a review of 34 randomized trials in people having cancer treatment found mixed results and could not say whether it works23.500 to 1,500 mg/dayWith fat mealDiscuss timing around chemo with oncologist. Highly absorbable forms may harm the liver24.
Mushroom Extracts (shiitake extract, maitake)Small trials are mixed: during chemotherapy a shiitake extract did not reduce bone marrow suppression, a maitake extract raised some immune measures and lowered others, and in head and neck cancer a maitake fraction eased chemoradiotherapy side effects25.1 to 3 g/dayEmpty stomachTell your oncology team before taking it; these extracts can lower as well as raise immune function25.
L-GlutamineA small randomized study in chest chemoradiotherapy found less inflammation of the esophagus, but no agent is recommended for preventing chemotherapy nerve damage26. Supports muscle.10 to 30 g/day during chemoDivided dosesDiscuss with oncologist; whether it could feed tumors is debated.
MelatoninAnti-tumor effects in the lab, but in a randomized placebo-controlled trial in advanced non-small cell lung cancer, melatonin with chemotherapy did not change survival or side effects27. Improves sleep, supports immune function.Not recommended for lung cancer (the trial used 10 or 20 mg a night)Not applicableMelatonin is commonly sold at doses well above what is needed, and more is not better. Discuss it with your prescriber if you take sedatives, anticoagulants or immunosuppressants.
Dietary Fiber (rather than probiotic supplements)Gut microbiome composition is associated with checkpoint inhibitor response, but probiotic supplements appear to be the wrong way to act on it. In 128 melanoma patients on checkpoint blockade, probiotic supplement use was associated with lower microbiome diversity, and the best progression-free survival occurred in those with high dietary fiber and no probiotic use.19Aim for 30 g or more a day of dietary fiber from foodWith or without foodFeed the microbiome with fiber rather than supplementing organisms. Do not start a probiotic while on immunotherapy without your oncologist's agreement. Avoid unnecessary antibiotics around immunotherapy.
NAC (N-Acetyl Cysteine)Glutathione precursor. In a randomized trial of 2,592 people with head and neck or lung cancer, most of whom had smoked, two years of NAC gave no benefit in survival or second cancers28. Caution, controversial in lung cancer.Not recommended for lung cancer (the trial used 600 mg a day)Not applicableSome studies suggest it may protect cancer cells. Discuss carefully with your oncologist.
What to Expect

What to Expect Over Time

Treatment depends on cancer type, stage and molecular profile1; diet and supplements support it, never replace it.

Treatment and supportive care, together
First Weeks

Scans, a biopsy and, in advanced non-small cell lung cancer, molecular testing come first and guide treatment1. If you smoke, ask for stop-smoking support now. Before taking any supplement, tell your oncology team; some interact with treatment.

Months 1 to 3

Early-stage cancer usually means surgery, often with further treatment to lower recurrence risk, or radiation if surgery is not possible; advanced disease gets chemotherapy, targeted therapy or immunotherapy1. In metastatic non-small cell lung cancer, early palliative care alongside treatment improved quality of life and mood in a randomized trial18.

Months 3 to 12

After surgery, exercise training improves fitness, leg strength and breathlessness12. In advanced disease the aims are to prolong life, ease symptoms and protect quality of life, with supportive care at every stage1.

Long Term

Survivors can develop a second lung cancer, especially smokers, so stay smoke-free for good4 and avoid beta-carotene supplements2.

When to Seek Care

Call 911 or go to the emergency department if you are struggling to breathe, have chest or upper back pain, or are coughing up more than a few streaks of blood; smaller streaks need an urgent appointment29. Call 911 or go to the emergency department for a seizure, sudden weakness, confusion, trouble speaking or new back pain with leg weakness or numbness30. Swelling of the face or neck can mean a blocked vein in the chest: contact your cancer team right away or get emergency care29. On chemotherapy, any fever of 100.5ยฐF (38ยฐC) or higher is an emergency: call your cancer team's urgent line or get emergency care now31.

📬

Get new guides in your inbox. Once a month: new condition guides and research updates, including the trials that did not work. Free, no spam, and you can unsubscribe in one click.

Sign up

Next Steps

Screening Saves Lives

If you've smoked 20+ pack-years, are 50 to 80, and smoke now or quit within the past 15 years, US guidance recommends annual low-dose CT, which aims to find lung cancer early, sometimes before symptoms5. Together with smoking cessation, modern targeted therapies and immunotherapy, screening has improved lung cancer outcomes. Don't delay screening, and never give up on smoking cessation, even after diagnosis.

Explore Pneumonia & Bronchitis โ†’ Explore COPD โ†’

References & Evidence Notes

Each numbered entry below is either a source you can follow or a note setting out what the evidence does and does not support. Both are numbered together so the markers in the text line up.

Last reviewed October 20, 2026. Supplement entries are cross-checked against the NIH National Center for Complementary and Integrative Health and the Linus Pauling Institute Micronutrient Information Center.32 Nothing on this page treats lung cancer. Holistic care is supportive only and conventional oncology is essential for any cure. Two warnings matter more than anything else here. First, if you smoke or used to smoke, do not take beta-carotene supplements: two large randomized trials found they increased lung cancer incidence and mortality in smokers. Second, avoid high-dose antioxidant supplements during chemotherapy or radiation therapy, which work partly through oxidative damage. Tell your oncology team about every supplement you take, and if you smoke, quitting is the single most valuable thing on this page, including after a diagnosis. Diet and supplements are not an alternative to surgery, chemotherapy, radiation therapy or immunotherapy, and no dietary change should delay or replace treatment decided with your oncology team. Several supplements interact with cancer treatment.

  1. On lung cancer worldwide: WHO states that lung cancer is the leading cause of cancer cases and deaths worldwide, with an estimated 2.5 million new cases and 1.8 million deaths in 2022; that non-small cell lung cancer accounts for around 85% of cases, while small cell lung cancer is less common but typically more aggressive; that smoking is the primary risk factor, with secondhand smoke, outdoor and household air pollution, workplace exposures such as asbestos, silica and diesel exhaust, radon, chronic lung disease and genetic susceptibility also important; and that treatment depends on the type, stage and molecular profile of the cancer, with supportive and palliative care important at every stage, WHO, lung cancer. ↩
  2. On beta-carotene, the most important safety item on this page. The Beta-Carotene and Retinol Efficacy Trial (CARET), N Engl J Med. 1996, PubMed 8602180, and the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study (ATBC), N Engl J Med. 1994, PubMed 8127329, both found beta-carotene supplementation increased lung cancer incidence and mortality in smokers and asbestos-exposed workers. CARET was stopped early for harm. Beta-carotene from food is not the same thing as a supplement, and the harm signal is specific to supplementation in people who smoke or have smoked. ↩
  3. SEER (National Cancer Institute) lung and bronchus cancer statistics. seer.cancer.gov. Source for the estimate of 229,410 new US diagnoses in 2026, lung cancer as the leading cause of cancer death in both men and women in the US, and stage at diagnosis: 24% of lung cancers are found while still localized and about half after spread to distant organs. ↩
  4. On causes: CDC states that cigarette smoking is the number one risk factor for lung cancer, linked to about 80% of US lung cancer deaths, that people who smoke are 15 to 30 times more likely to get or die from lung cancer, and that risk goes down after quitting. It lists secondhand smoke, indoor radon, workplace substances such as asbestos, arsenic, diesel exhaust, silica and chromium, air pollution, a personal or family history of lung cancer, HIV, radiation therapy to the chest and beta-carotene supplements as further risk factors, the supplement risk being greatest in people who smoke a pack a day or more and higher still with daily alcohol, while beta-carotene from food does not raise risk, CDC, lung cancer risk factors. ↩
  5. US Preventive Services Task Force, lung cancer screening, 2021. uspreventiveservicestaskforce.org. Annual low-dose CT for adults aged 50 to 80 with a 20 pack-year history who currently smoke or quit within the past 15 years. Uptake among eligible adults remains low: in national survey data for 2022, 17% of 28,071 eligible adults had been screened, PubMed 39269271. ↩
  6. National Lung Screening Trial, N Engl J Med. 2011;365:395-⁠409 (20% reduction in lung cancer mortality with low-dose CT against chest radiography) PubMed 21714641, and the NELSON trial, N Engl J Med. 2020;382:503-⁠513 (24% reduction in lung cancer deaths in men at 10 years against no screening) PubMed 31995683. ↩
  7. On lung cancer types and early-stage surgery: National Cancer Institute treatment summaries state that adenocarcinoma accounts for about 40% of lung cancers, squamous cell carcinoma 25% and large cell carcinoma 10%, and small cell lung cancer about 15%; that surgery is potentially the most curative option for non-small cell lung cancer; and that people with resectable disease who cannot have surgery are candidates for curative radiation therapy, with stereotactic body radiation therapy widely adopted for medically inoperable stage I disease, NCI PDQ, non-small cell lung cancer, NCI PDQ, small cell lung cancer. ↩
  8. On paraneoplastic syndromes: MedlinePlus states that Lambert-Eaton myasthenic syndrome is an autoimmune disorder often associated with cancers such as small cell lung cancer or with other autoimmune disorders, MedlinePlus, Lambert-Eaton syndrome, and lists the causes of SIADH as including certain medicines, surgery, brain injury, infection or stroke, tuberculosis, pneumonia and other lung diseases, and cancer, especially small cell lung cancer, MedlinePlus, SIADH. ↩
  9. On radon: the US Environmental Protection Agency estimates that radon is the leading cause of lung cancer in people who have never smoked and the second leading cause overall, responsible for about 21,000 US lung cancer deaths a year, with a much higher risk in people who smoke, EPA, health risk of radon. ↩
  10. On screening in the UK: NHS guidance states that people aged 55 to 74 who have ever smoked may be invited for lung cancer screening with a lung health check, currently available in parts of England as targeted screening is rolled out, and that screening aims to find lung cancer early, sometimes before there are symptoms, NHS, lung cancer screening. ↩
  11. KEYNOTE-⁠024: Reck M, et al. Pembrolizumab versus chemotherapy for PD-L1-⁠positive NSCLC. N Engl J Med. 2016;375:1823-⁠1833. PubMed 27718847. Basis for first-line pembrolizumab monotherapy at PD-L1 expression of 50% or above. Treatment selection depends on driver mutations, histology and performance status, and belongs with an oncology team. ↩
  12. On exercise after surgery: a Cochrane review of eight randomized trials in 450 people who had surgery for non-small cell lung cancer found that exercise training improved exercise capacity and leg muscle strength, with signs of better physical quality of life and less breathlessness; effects on fatigue were uncertain, and deaths were not reported, PubMed 31204439. ↩
  13. On high-dose antioxidants during treatment: radiation therapy and several chemotherapies act partly through oxidative damage to tumor cells, so high-dose antioxidant supplementation during treatment carries a theoretical risk of reducing efficacy. Evidence is mixed rather than settled, so the decision belongs with the treating oncologist. A 2024 review of 24 systematic reviews found conclusions ranging from harm to no difference to benefit, always with caveats about the size and quality of the trials, PubMed 39078314. The main human signal comes from a breast cancer chemotherapy trial rather than from lung cancer, PubMed 31855498. ↩
  14. On smoking cessation after diagnosis: a systematic review of observational studies, mostly of early-stage lung cancer, found that continuing to smoke after diagnosis was associated with higher death and recurrence rates than quitting, and described this as preliminary evidence that quitting improves outcomes, PubMed 20093278. The risk of getting lung cancer goes down after quitting, CDC, lung cancer risk factors. ↩
  15. On diet and lung cancer: the World Cancer Research Fund finds that high-dose beta-carotene supplements increase lung cancer risk in current and former smokers, and rates the evidence as limited for other dietary factors, including that vegetables and fruit may lower risk in people who smoke or used to smoke and that alcohol may raise it; it advises against changing behavior on the basis of these limited findings alone, World Cancer Research Fund, lung cancer. ↩
  16. On targeted therapy in non-small cell lung cancer: National Cancer Institute treatment guidance states that molecularly targeted therapies, aimed at alterations that include EGFR, ALK, ROS1 and BRAF, have improved survival for some patients with metastatic disease, which is why molecular testing belongs in the workup of advanced disease, NCI PDQ, accessed 2026. ↩
  17. On first-line immunotherapy without a targetable mutation: in a randomized trial of 616 people with metastatic nonsquamous non-small cell lung cancer, adding a checkpoint inhibitor to platinum chemotherapy lengthened overall survival, with improvement across all PD-L1 categories evaluated; in another randomized trial, a combination of two checkpoint inhibitors lengthened survival against chemotherapy whether PD-L1 expression was 1% or more or below 1%, PubMed 29658856, PubMed 31562796. ↩
  18. On early palliative care: in a randomized trial of 151 people with newly diagnosed metastatic non-small cell lung cancer, palliative care started early alongside standard cancer care improved quality of life and mood, led to less aggressive care at the end of life, and was followed by longer median survival (11.6 against 8.9 months), PubMed 20818875. ↩
  19. Spencer CN, et al. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response. Science. 2021;374(6575):1632-⁠1640. science.org. In 128 patients on immune checkpoint blockade, higher dietary fiber was associated with significantly improved progression-free survival, and the most marked benefit was in those with high fiber intake and no probiotic supplement use. Over 40% of patients reported taking probiotics, which was associated with lower gut microbiome diversity. Two honest caveats: this was a melanoma cohort, not lung cancer, and it is observational. The drug class and the proposed mechanism are the same, which is why it is cited here, but the effect has not been measured in lung cancer specifically. It is enough to stop recommending probiotic supplements to people on checkpoint inhibitors. ↩
  20. On vitamin D after surgery: in a randomized, double-blind trial of 155 people with non-small cell lung cancer, vitamin D (1,200 IU a day for a year after surgery) did not improve relapse-free or overall survival against placebo; a benefit was seen only in a subgroup with early-stage adenocarcinoma and low vitamin D levels, which needs confirming, PubMed 30018118. ↩
  21. On omega-⁠3 and cancer weight loss: a 2026 umbrella review of systematic reviews of randomized trials found that omega-⁠3 fatty acids gave small improvements in health-related quality of life but inconsistent effects on body weight, lean body mass and inflammation, with most evidence of low or very low certainty, PubMed 41950300. ↩
  22. Gencer B, Djousse L, Al-Ramady OT, Cook NR, Manson JE, Albert CM. Effect of long-term marine omega-⁠3 fatty acids supplementation on the risk of atrial fibrillation in randomized controlled trials of cardiovascular outcomes: a systematic review and meta-analysis. Circulation. 2021;144(25):1981-⁠1990. PubMed 34612056. Seven trials with 81,210 people followed for about 5 years: omega-⁠3 supplements were linked to a higher risk of atrial fibrillation (hazard ratio 1.25), more so in trials of more than 1 g a day (1.49), and the risk rose with each additional gram. ↩
  23. On curcumin during cancer treatment: a 2025 systematic review of 34 randomized trials in 2,580 people having cancer treatment, mostly head and neck, breast, prostate and colorectal cancer, found heterogeneous results with moderate to high risk of bias, and concluded that no clear statement on whether curcumin works could be made, PubMed 39425780. ↩
  24. On curcumin safety: the NIH National Center for Complementary and Integrative Health states that there is not enough evidence to conclude that turmeric or curcumin helps any health condition, that highly bioavailable curcumin formulations may harm the liver, and that some herbs and medicines interact in harmful ways, NCCIH, turmeric. ↩
  25. On medicinal mushroom extracts: in a randomized, placebo-controlled trial of 28 women having chemotherapy for ovarian or peritoneal cancer, a shiitake mushroom extract (3 g a day) did not change immune cell counts, bone marrow suppression or quality of life, and reduced nausea and vomiting but increased muscle pain, PubMed 28440968. In a dose-escalation trial in 34 women after breast cancer treatment, a maitake extract raised some immune measures and lowered others, and the authors warn that such extracts may depress as well as enhance immune function, PubMed 19253021. In a randomized, placebo-controlled trial of 141 people having chemoradiotherapy for laryngeal or pharyngeal cancer, a maitake fraction was followed by fewer severe side effects and better quality of life, PubMed 36070433. ↩
  26. On glutamine: in a randomized study of 60 people having chemoradiotherapy for advanced non-small cell lung cancer, oral glutamine was followed by less moderate or severe inflammation of the esophagus, PubMed 30813149, but the American Society of Clinical Oncology guideline on chemotherapy nerve damage found that no agent is recommended for preventing it, PubMed 32663120. ↩
  27. On melatonin: in a randomized, double-blind, placebo-controlled trial in advanced non-small cell lung cancer, 10 or 20 mg of melatonin with chemotherapy did not change survival or side effects, with a trend toward better quality of life, PubMed 25503168. ↩
  28. On N-acetylcysteine: in the EUROSCAN randomized trial of 2,592 people with head and neck or lung cancer, most of whom had smoked, two years of N-acetylcysteine (600 mg a day) gave no benefit in survival, event-free survival or second primary cancers, PubMed 10861309. ↩
  29. On urgent symptoms: NHS guidance advises calling emergency services or going to an emergency department for struggling to breathe, chest or upper back pain, or coughing up more than a few spots or streaks of blood, and an urgent appointment with a family doctor for smaller amounts. Swelling of the face or neck can come from a blocked large vein in the chest, most often caused by lung cancer, which needs the cancer team contacted right away, NHS, lung cancer symptoms, NHS, coughing up blood, Macmillan, superior vena cava obstruction. ↩
  30. On nervous system emergencies: NHS guidance says to call emergency services at once for signs of a stroke, which include weakness or numbness down one side of the body, difficulty speaking and confusion, NHS, stroke symptoms, and for a first seizure or one lasting more than 5 minutes, NHS, seizures. NICE guidance says that in a person with cancer, limb weakness, numbness, difficulty walking or bladder or bowel problems suggest spinal cord compression, to be treated as an oncological emergency, and that back pain can signal cancer in the spine, NICE NG234. ↩
  31. On fever during treatment: the National Cancer Institute states that infections during cancer treatment can be life-threatening and need urgent medical attention, and lists a fever of 100.5ยฐF (38ยฐC) or higher among the signs; NHS guidance says to call your care team now if you have a high temperature, NCI, infection and neutropenia, NHS, chemotherapy side effects. ↩
  32. National Center for Complementary and Integrative Health (NIH), nccih.nih.gov, and the Linus Pauling Institute Micronutrient Information Center, lpi.oregonstate.edu/mic. ↩